As of 2024-09-14, the Relative Valuation of Cytosorbents Corp (CTSO) is (17.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.08 USD, the upside of Cytosorbents Corp based on Relative Valuation is -1701.2%.
The range of the Relative Valuation is (18.34) - (16.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 39.1x - 44.6x | 41.9x |
| Forward P/E multiples | 30.7x - 34.4x | 31.8x |
| Fair Price | (18.34) - (16.13) | (17.29) |
| Upside | -1797.8% - -1593.7% | -1701.2% |
| Date | P/E |
| 2024-09-13 | -2.30 |
| 2024-09-12 | -2.26 |
| 2024-09-11 | -2.13 |
| 2024-09-10 | -2.13 |
| 2024-09-09 | -2.20 |
| 2024-09-06 | -2.20 |
| 2024-09-05 | -2.17 |
| 2024-09-04 | -2.11 |
| 2024-09-03 | -2.17 |
| 2024-08-30 | -2.24 |
| 2024-08-29 | -2.17 |
| 2024-08-28 | -2.15 |
| 2024-08-27 | -2.22 |
| 2024-08-26 | -2.28 |
| 2024-08-23 | -2.30 |
| 2024-08-22 | -2.22 |
| 2024-08-21 | -2.26 |
| 2024-08-20 | -2.24 |
| 2024-08-19 | -2.24 |
| 2024-08-16 | -2.22 |
| 2024-08-15 | -2.17 |
| 2024-08-14 | -2.06 |
| 2024-08-13 | -1.91 |
| 2024-08-12 | -1.90 |
| 2024-08-09 | -2.24 |
| 2024-08-08 | -2.22 |
| 2024-08-07 | -2.32 |
| 2024-08-06 | -2.15 |
| 2024-08-05 | -2.26 |
| 2024-08-02 | -2.56 |
| 2024-08-01 | -2.45 |
| 2024-07-31 | -2.56 |
| 2024-07-30 | -2.53 |
| 2024-07-29 | -2.58 |
| 2024-07-26 | -2.20 |
| 2024-07-25 | -2.20 |
| 2024-07-24 | -2.15 |
| 2024-07-23 | -2.19 |
| 2024-07-22 | -2.24 |
| 2024-07-19 | -2.24 |
| 2024-07-18 | -2.22 |
| 2024-07-17 | -2.35 |
| 2024-07-16 | -2.39 |
| 2024-07-15 | -2.28 |
| 2024-07-12 | -2.30 |
| 2024-07-11 | -2.08 |
| 2024-07-10 | -2.11 |
| 2024-07-09 | -2.15 |
| 2024-07-08 | -2.15 |
| 2024-07-05 | -1.94 |